Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Lesprit

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
La Revue Du Praticien|December 5, 2018
Can the duration of antibiotic therapy be reduced without impairing its efficacy?Bernard Castan, Éric Bonnet, Rémy Gauzit, et al.
Journal of Vascular Surgery|August 12, 2008
Aortoiliac aneurysms infected by Campylobacter fetusFrédéric Cochennec, Laure Gazaigne, Philippe Lesprit, et al.
Infectious Diseases Now|June 22, 2026
Bacterial epidemiology of male urinary tract infections in France: An expert reviewYvan Caspar, Vincent Cattoir, Agnès Lefort, et al.
The French Journal of Urology|September 19, 2024
Appropriate antimicrobial prescribing for bacteriuria before urological procedures: A room for improvementThibaud Garnier, Philippe Lesprit, Clément Sarrazin, et al.
Infectious Diseases Now|October 11, 2025
Efficacy of antimicrobial stewardship indicators in assessing the impact of a regional antibiotic therapy center in primary care and nursing homesRenan Le Cras, Patricia Vidal, Patricia Pavese, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 11, 2019
Continuous infusion of ceftolozane/tazobactam is associated with a higher probability of target attainment in patients infected with Pseudomonas aeruginosaBenoît Pilmis, Grégoire Petitjean, Philippe Lesprit, et al.
Journal of Clinical Epidemiology|March 14, 2009
A new endpoint definition improved clinical relevance and statistical power in a vaccine trialGaëlle Pédrono, Rodolphe Thiébaut, Ahmadou Alioum, et al.
Archives of Dermatology|December 23, 2009
Septic facial vein thrombosis due to Panton-Valentine leukocidin-positive Staphylococcus aureusNorah Kramkimel, Emilie Sbidian, Tu Anh Duong, et al.
Infectious Diseases Now|June 20, 2026
Which investigations should be performed after a first episode of urinary tract infection in men?Benjamin Soudais, Franck Bruyère, Emmanuel Forestier, et al.
Intensive Care Medicine|August 16, 2012
Clinical impact and risk factors for colonization with extended-spectrum β-lactamase-producing bacteria in the intensive care unitKeyvan Razazi, Lennie P G Derde, Marine Verachten, et al.
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
La Revue Du Praticien|December 5, 2018
Can the duration of antibiotic therapy be reduced without impairing its efficacy?Bernard Castan, Éric Bonnet, Rémy Gauzit, et al.
Journal of Vascular Surgery|August 12, 2008
Aortoiliac aneurysms infected by Campylobacter fetusFrédéric Cochennec, Laure Gazaigne, Philippe Lesprit, et al.
Infectious Diseases Now|June 22, 2026
Bacterial epidemiology of male urinary tract infections in France: An expert reviewYvan Caspar, Vincent Cattoir, Agnès Lefort, et al.
The French Journal of Urology|September 19, 2024
Appropriate antimicrobial prescribing for bacteriuria before urological procedures: A room for improvementThibaud Garnier, Philippe Lesprit, Clément Sarrazin, et al.
Infectious Diseases Now|October 11, 2025
Efficacy of antimicrobial stewardship indicators in assessing the impact of a regional antibiotic therapy center in primary care and nursing homesRenan Le Cras, Patricia Vidal, Patricia Pavese, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 11, 2019
Continuous infusion of ceftolozane/tazobactam is associated with a higher probability of target attainment in patients infected with Pseudomonas aeruginosaBenoît Pilmis, Grégoire Petitjean, Philippe Lesprit, et al.
Journal of Clinical Epidemiology|March 14, 2009
A new endpoint definition improved clinical relevance and statistical power in a vaccine trialGaëlle Pédrono, Rodolphe Thiébaut, Ahmadou Alioum, et al.
Archives of Dermatology|December 23, 2009
Septic facial vein thrombosis due to Panton-Valentine leukocidin-positive Staphylococcus aureusNorah Kramkimel, Emilie Sbidian, Tu Anh Duong, et al.
Infectious Diseases Now|June 20, 2026
Which investigations should be performed after a first episode of urinary tract infection in men?Benjamin Soudais, Franck Bruyère, Emmanuel Forestier, et al.
Intensive Care Medicine|August 16, 2012
Clinical impact and risk factors for colonization with extended-spectrum β-lactamase-producing bacteria in the intensive care unitKeyvan Razazi, Lennie P G Derde, Marine Verachten, et al.
Pageof 6